You searched for metabolic diseases - Page 30 of 64

Interview 6 Mar 2017

How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains

We talked to the CEO of Bicycle Therapeutics, Kevin Lee, about how his company’s technology could cure not just cancer but also a raft of other diseases. Bicycle Therapeutics made…

March 6, 2017 - 7 minutesmins - By Evelyn Warner

News and Trends 30 May 2023

Pancreatic cancer microbiome discovery holds treatment hope

…neurological diseases such as Alzheimer’s disease and Parkinson’s disease. “Our bacteriophage-based new drug is undoubtedly a ‘first-in-concept’ drug that can effectively control various immune-related diseases. Therefore, we will continue to…

May 30, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 12 Apr 2017

Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics

…specific class of so called ‘macrocyclic drugs‘, which are chemically defined by a ring structure. The company’s pipeline is covering a broad range of diseases such as leukemia, infectious diseases…

April 12, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 29 Sep 2022

Treatment for adults with chronic skin condition approved by FDA

…a global collaboration agreement. To date, dupilumab has been studied across more than 60 clinical trials involving more than 10,000 patients with various chronic diseases driven in part by type…

September 29, 2022 - 4 minutesmins - By Liza Laws

Rare disease clinical trials: how can complex innovative designs help overcome the challenges?

Complex innovative designs: tackling rare disease clinical trial challenges

…7,000 rare diseases are known today, affecting more than 400 million people globally. For most of these diseases, no treatment is available yet. At the same time, precision therapy approaches…

April 23, 2024 - 7 minutesmins - By Ute Boronowsky

In Depth 19 Apr 2023

How Vaccine Platforms Can Prepare Us for Future Pandemics

…the risk of a zoonotic spillover — the transmission of diseases from animals to humans. With more than five new infectious diseases emerging each year, there’s always the threat of…

April 19, 2023 - 7 minutesmins - By Sachin Rawat

News and Trends 13 Dec 2016

European Pharma closes 2016 by launching new Biotech Startups

…regenerative medicine for diseases affecting the nervous and cardiovascular systems. Given that CNS diseases are marked by neuronal degeneration and CV diseases by muscular degeneration, regenerative medicine seems like the…

December 13, 2016 - 2 minutesmins - By Evelyn Warner

rnai rna intereference silence therapeutics mallinckrodt

More News! 19 Jul 2019

Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up to €553M

The UK-based biotech Silence Therapeutics has signed a deal worth up to €553M ($693M) with the UK pharma company Mallinckrodt to develop RNA interference (RNAi) therapies for autoimmune diseases. Mallinckrodt…

July 19, 2019 - 2 minutesmins - By Jonathan Smith

paris ermium therapeutics autoimmune disease

Startup Scout 18 Oct 2019

This Biotech Fights Autoimmune Disease with Rare Immune Cells

…approved to treat autoimmune conditions such as NSAIDs and steroids typically suppress the whole immune system, leaving patients susceptible to infections. “Those diseases are disabling diseases, with drugs that are…

October 18, 2019 - 3 minutesmins - By Jonathan Smith

Best in Biotech 24 Dec 2018

Looking Back on 2018: Our 10 Most Popular Interviews

…target a wide arrange of rare genetic diseases, including several forms of blindness. 4. Bravo! An interview with the CEO of Takeda’s recent cell therapy target After beginning his career…

December 24, 2018 - 8 minutesmins - By Helen Albert

Interview 9 Nov 2017

Meet the Spin-Out Queen Taking on Neurological Diseases

Mary Kerr, CEO of NeRRe and Managing Director of KanDy, told us how its approaches could change the face of therapies for neuronal hypersensitivity and women’s health indications. Mary Kerr’s…

November 9, 2017 - 4 minutesmins - By Alex Dale

In Depth 4 Jan 2021

What Does the Next Decade Have in Store for European Biotech?

…Bause, who leads a venture creation program at the investment firm Apollo Health Ventures. Gene therapy is most often associated with curing genetic diseases and treating cancer, but Bause sees…

January 4, 2021 - 9 minutesmins - By Karen O’Hanlon Cohrt

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains

Pancreatic cancer microbiome discovery holds treatment hope

Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics

Treatment for adults with chronic skin condition approved by FDA

Complex innovative designs: tackling rare disease clinical trial challenges

How Vaccine Platforms Can Prepare Us for Future Pandemics

European Pharma closes 2016 by launching new Biotech Startups

Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up to €553M

This Biotech Fights Autoimmune Disease with Rare Immune Cells

Looking Back on 2018: Our 10 Most Popular Interviews

Meet the Spin-Out Queen Taking on Neurological Diseases

What Does the Next Decade Have in Store for European Biotech?

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!